Multicenter study sponsored by SELNET to evaluate cirtuvivint as a second-line monotherapy in selected sarcoma subtypes. SAN DIEGO, May 01, 2025 (GLOBE NEWSWIRE) -- Biosplice Ther ...

For the second time in a year, the Southern Command visits the Naval Base in Ushuaia, which it projects as a gateway to the ...

An Ipsos global poll this month showed that 76 per cent of Peruvians believe the US will have a positive influence on the ...

U.K.-French film company Alief has pounced on the worldwide sales rights to ‘Luna Rosa, The 7th Ascension of Atabey.’ ...